1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. PRESTIGE CONSUMER HEALTHCARE INC
Prestige Consumer Healthcare Inc
XNYS: PBH
46.75 0.82 (1.79%)
2.0M

XNYS 15 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Acquisition
Prestige Consumer Healthcare to acquire Australian skin-care maker LaCorium for ~$150 million See details

Prestige Consumer Healthcare Inc - PBH - stock price prediction, stock price target, analyst ratings from 7 analysts

Prestige Consumer Healthcare Inc has a share price target of US$ 70, revenue growth forecast of 6.9%, and profit growth estimate of 9.4% for FY27, based on top 7 analyst calls.